Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of Cellectar Biosciences (NASDAQ:CLRB – Get Free Report) in a ...
PTC Therapeutics (NASDAQ:PTCT) Given Overweight Rating at Morgan Stanley
Morgan Stanley restated their overweight rating on shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) in a research note issued to investors on Friday,Benzinga reports. They currently have a ...